Iqvia (NYSE:IQV) updated its first quarter earnings guidance on Wednesday. The company provided EPS guidance of $1.23-1.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.20. Iqvia also updated its FY18 guidance to $5.35-5.60 EPS.
Several research firms have commented on IQV. Mizuho lowered shares of Iqvia from a buy rating to a neutral rating and set a $90.00 price target on the stock. in a report on Thursday, November 9th. SunTrust Banks reaffirmed a hold rating and issued a $114.00 price target on shares of Iqvia in a report on Friday, November 3rd. Zacks Investment Research lowered shares of Iqvia from a buy rating to a hold rating in a report on Friday, January 19th. KeyCorp reaffirmed a sector weight rating and issued a $100.00 price target on shares of Iqvia in a report on Friday, November 10th. Finally, Morgan Stanley upped their price target on shares of Iqvia from $96.00 to $121.00 and gave the company an overweight rating in a report on Thursday, November 9th. Seven investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of Buy and a consensus price target of $109.71.
Iqvia (NYSE:IQV) opened at $100.06 on Wednesday. The firm has a market cap of $20,513.85, a PE ratio of 22.52, a price-to-earnings-growth ratio of 1.34 and a beta of 0.61. Iqvia has a 1 year low of $75.94 and a 1 year high of $110.67. The company has a debt-to-equity ratio of 1.29, a current ratio of 1.22 and a quick ratio of 1.22.
Iqvia Company Profile
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.